Press Releases

Month Year

Month Year

Oct 18, 2016

Insmed Announces Publication of Phase 2 Study of ARIKAYCE in Treatment-Refractory Nontuberculous Mycobacterial Lung Disease

Data in American Journal of Respiratory and Critical Care Medicine demonstrate ARIKAYCE's potential to achieve early and sustained negative sputum cultures

Read more
Oct 5, 2016

Insmed Announces Worldwide License Agreement with AstraZeneca for Oral DPP1 Inhibitor

Read more
Sep 27, 2016

Insmed Appoints Roger Adsett as Chief Commercial Officer

Read more
Sep 8, 2016

Insmed to Participate at September Investor Conferences

Read more
Aug 31, 2016

Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress

Read more
Aug 4, 2016

Insmed Reports Second Quarter 2016 Financial Results

Read more
Jun 8, 2016

Insmed Announces Withdrawal of Marketing Authorization Application for ARIKAYCE™ in Europe

Read more
May 9, 2016

Insmed to Present at the Bank of America Global Healthcare Conference

Read more
May 5, 2016

Insmed Reports First Quarter 2016 Financial Results

Read more
May 3, 2016

Insmed Announces Upcoming Presentations at the American Thoracic Society 2016 International Meeting

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation